Evidence map›Paper›PMID 33209374›Full record

ArticleJournal of thoracic disease2020

Impact of cardiovascular risk factors on the clinical presentation and survival of pulmonary embolism without identifiable risk factor.

Nuria Rodríguez-Núñez, Alberto Ruano-Raviña, Adriana Lama, Lucía Ferreiro, Jorge Ricoy, José M Álvarez-Dobaño, Juan Suárez-Antelo, M Elena Toubes, Carlos Rábade, Antonio Golpe and 3 more

Open access · diamondAbstract read
In one paragraph

Article in Journal of thoracic disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Nuria Rodríguez-NúñezDepartment of Pulmonology, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain.
Alberto Ruano-RaviñaDepartment of Preventive Medicine and Public Health, Universidad de Santiago de Compostela, Santiago de Compostela, Spain.
Adriana LamaDepartment of Pulmonology, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain.
Lucía FerreiroDepartment of Pulmonology, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain.
Jorge RicoyDepartment of Pulmonology, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain.
José M Álvarez-DobañoDepartment of Pulmonology, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain.
Juan Suárez-AnteloDepartment of Pulmonology, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain.
M Elena ToubesDepartment of Pulmonology, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain.
Carlos RábadeDepartment of Pulmonology, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain.
Antonio GolpeDepartment of Pulmonology, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain.
Tamara LouridoDepartment of Pulmonology, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain.
Francisco Javier González-BarcalaDepartment of Pulmonology, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain.
Luis ValdésDepartment of Pulmonology, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain.
Complejo Hospitalario Universitario de Santiago · ESInstituto de Investigación Sanitaria de Santiago · ESCentro de Investigación Biomédica en Red de Epidemiología y Salud Pública · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe nature of pulmonary embolism (PE) without identifiable risk factor (IRF) remains unclear. The objective of this study is to investigate the potential relationship between cardiovascular risk factors (CVRFs) and PE without IRF (unprovoked) and assess their role as markers of disease severity and prognosis.

methodsA case-control study was performed of patients with PE admitted to our hospital [2010-2019]. Subjects with PE without IRF were included in the cohort of cases, whereas patients with PE with IRF were allocated to the control group. Variables of interest included age, active smoking, obesity, and diagnosis of arterial hypertension, dyslipidemia or diabetes mellitus.

resultsA total of 1,166 patients were included in the study, of whom 64.2% had PE without IRF. The risk for PE without IRF increased with age [odds ratio (OR): 2.68; 95% confidence interval (CI): 1.95-3.68], arterial hypertension (OR: 1.63; 95% CI: 1.27-2.07), and dyslipidemia (OR: 1.63; 95% CI: 1.24-2.15). The risk for PE without IRF was higher as the number of CVRF increased, being 3.99 (95% CI: 2.02-7.90) for subjects with ≥3 CVRF. The percentage of high-risk unprovoked PE increased significantly as the number of CVRF rose [0.6% for no CVRF; 23.8% for a CRF, P<0.001 (OR: 9.92; 95% CI: 2.82-34.9); 37.5% for two CRFs, P<0.001 (OR: 14.8; 95% CI: 4.25-51.85); and 38.1% for ≥3, P<0.001 (OR: 14.1; 95% CI: 4.06-49.4)]. No significant differences were observed in 1-month survival between cases and controls, whereas differences in 24-month survival reached significance.

conclusionsA relationship was observed between CVRF and PE without IRF, as the risk for unprovoked PE increased with the number of CVRF. In addition, the number of CVRF was associated with PE without IRF severity, but not with prognosis.

Indexed as

cardiovascular risk factors (CVRFs)mortalityno identifiable risk factor (no IRF)Pulmonary embolism (PE)severityunprovoked pulmonary embolism (unprovoked PE)venous thromboembolism

Identifiers

PMID33209374
PMCPMC7656446
OpenAlexW3092573507

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.